Artificial Intelligence

Stanford University’s Venture Capital Fund, Stanford-StartX Fund, Sues One of Their Portfolio Companies, MedWhat.com, Inc.

Ashish Sukhadeve

Lawsuit filed in Superior Court of California.

San Francisco, CA — May 8th, 2018Stanford University's venture capital fund, Stanford-StartX Fund LLC., has filed a lawsuit against their portfolio company MedWhat.com, Inc. in the Superior Court of California in the County of San Francisco. The filing to the court was done on April 9th, 2018, with the case number CGC-18-565596.

Stanford-StartX Fund is a partnership between Stanford University, Stanford Health Care, and StartX that invests in Stanford University's students, alumni, professors, and research companies through the Stanford University accelerator StartX.

MedWhat.com, Inc. is a medical artificial intelligence company that participated in the 2013 StartX program and is affiliated with Stanford University. The Stanford-StartX Fund was invested in MedWhat in 2014, 2015, and 2017. MedWhat develops medical deep learning, machine learning, natural language processing and personalized medicine. MedWhat is building a unified algorithmic architecture to achieve human-level intelligence in medicine. The team is made of a group of doctors, data scientist, A.I. PhDs and medical researchers from Stanford.

For more information on the lawsuit:

Arturo Devesa: info@medwhat.com
www.medwhat.com

Suzanne Fletcher: suzanne@startx.stanford.edu
Susan Weinstein: susan.weinstein@stanford.edu
https://startx.com/ and https://www.stanford.edu/

Join our WhatsApp Channel to get the latest news, exclusives and videos on WhatsApp

                                                                                                       _____________                                             

Disclaimer: Analytics Insight does not provide financial advice or guidance. Also note that the cryptocurrencies mentioned/listed on the website could potentially be scams, i.e. designed to induce you to invest financial resources that may be lost forever and not be recoverable once investments are made. You are responsible for conducting your own research (DYOR) before making any investments. Read more here.

4 Best Altcoins for Next Bull Run That Analysts Are Quietly Accumulating

Buying This Token Under $1 is a Once-in-a-Lifetime Opportunity, Like Ethereum at $10 or XRP at $0.0028

Cardano (ADA) Turned Early Buyers Super Rich With $3.10 ATH; This New Crypto Will Explode With Bigger ROI

Is Unstaked Building The Best AI Crypto Platform of 2025? Let’s Find Out

Crypto ICO Spotlight: Web3 ai Says It’s Not Another Overhyped Presale. But Is That True? Let’s Break it Down